Nerve growth factor (NGF) and transforming growth factor-β2 (TGF-β2) are cytokines which have known immunological effects. An elevated level of NGF has been reported in certain autoimmune diseases, whereas TGF-β2 is an immunosuppressor which is known to play a role in regulating cell proliferation. A role of this cytokine has been proposed in the pathogenesis of type-1 diabetes mellitus (IDDM), but no clinical studies have yet measured its serum level in this disease. In this study we measured the levels of NGF and TGF-β2 in the sera of patients with IDDM (n ϭ 26) and values were compared to those of age-matched normal subjects (n ϭ 27) and also to patients with type-2 diabetes mellitus (NIDDM) (n ϭ 26) with similar HbA1c levels and an equal duration of diabetes. Serum NGF levels were significantly elevated in IDDM patients compared to those of age-matched controls ( p Ͻ .001) and NIDDM controls ( p Ͻ .01). TGF-β2 levels were lower in IDDM patients when compared with the healthy control ( p Ͻ .001) and the NIDDM control ( p Ͻ .05). There was no correlation between the levels of NGF and TGF-β2. The duration of diabetes and the level of HbA1c did not affect the NGF and TGF-β2 levels in the IDDM patients. We conclude that an increase in NGF and a suppression in TGF-β2 levels are present in patients with type-1 diabetes mellitus and that both cytokines may play independent roles in the pathogenesis of this disease.
INTRODUCTION
In the pathogenesis of autoimmune diseases there is a complex interplay among genetic, immune, and hormonal factors. Type-1 diabetes mellitus (IDDM) is an autoimmune condition resulting from a cell-mediated immune destruction of pancreatic β cells (Tisch & Mcdevitt, 1996) and evidence from animal models of IDDM incriminates cytokines in the initiation and outcome of this autoimmune disease (MandrupPoulson, Helqvist, Molvig, Wogenson, & Nerup, 1989) . The proper production of and interaction between different cytokines as immune effector molecules contribute to a well-balanced immune response, which if upset can have serious consequences in the pathogenesis of IDDM (Schattner, 1994) . Nerve growth factor (NGF), which is a member of the family of proteins known as neurotropins, has been shown to play an important role in the development and survival of peripheral, sympathetic, and sensory neurons (Levi-Montalcini, 1989) . Recently, a cytokine role for NGF has been described and it was shown that in certain autoimmune diseases, there is an elevation in its serum level. NGF is high in the serum of patients with rheumatoid arthritis and systemic lupus erythematosus (Dicou, Masson, Jabbour, & Nerriere, 1993) , allergic diseases, and asthma (Bonini, Lambiase, Bonini, Angelucci, Magrini, Manni, & Aloe, 1996) and in the cerebrospinal fluid of patients with multiple sclerosis
